Laboratorio Reig Jofre SA

24
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0165359029
EUR
2.47
-0.01 (-0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Laboratorio Reig Jofre SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
6.00
11.00
9.00
7.00
5.00
6.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-14.00
-3.00
-11.00
-3.00
-7.00
-2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1.00
31.00
19.00
16.00
14.00
22.00
Cash Flow from Investing Activities
-17.00
-31.00
-12.00
-12.00
-34.00
-30.00
Cash Flow from Financing Activities
16.00
5.00
-7.00
-2.00
13.00
9.00
Net Cash Inflow / Outflow
0.00
4.00
0.00
1.00
-6.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Laboratorio Reig Jofre SA
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
6.629
85.414
-79.00
-92.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-14.321
-31.533
17.00
54.58%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1.514
78.49
-77.00
-98.07%
Cash Flow from Investing Activities
-17.818
-299.019
282.00
94.04%
Cash Flow from Financing Activities
16.313
273.619
-257.00
-94.04%
Net Cash Inflow / Outflow
0.009
53.09
-53.00
-99.98%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -95.17% vs 63.95% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
1.51
31.34
-95.17%